Authors: Itoh, N Arai, H Urakami, K Ishiguro, K Ohno, H Hampel, H Buerger, K Wiltfang, J Otto, M Kretzschmar, H Moeller, HJ Imagawa, M Kohno, H Nakashima, K Kuzuhara, S Sasaki, H Imahori, K

Citation: N. Itoh et al., Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease, ANN NEUROL, 50(2), 2001, pp. 150-156

Authors: Hampel, H Buerger, K Kohnken, R Teipel, SJ Zinkowski, R Moeller, HJ Rapoport, SI Davies, P

Citation: H. Hampel et al., Tracking of Alzheimer's disease progression with cerebrospinal fluid tau protein phosphorylated at threonine 231, ANN NEUROL, 49(4), 2001, pp. 545-546

Authors: Du, Y Dodel, R Hampel, H Buerger, K Lin, S Eastwood, B Bales, K Gao, F Moeller, HJ Oertel, W Farlow, M Paul, S

Citation: Y. Du et al., Reduced levels of amyloid beta-peptide antibody in Alzheimer disease, NEUROLOGY, 57(5), 2001, pp. 801-805

Authors: Kohnken, R Buerger, K Zinkowski, R Miller, C Kerkman, D DeBernardis, J Shen, JF Moller, HJ Davies, P Hampel, H

Citation: R. Kohnken et al., Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid ofAlzheimer's disease patients, NEUROSCI L, 287(3), 2000, pp. 187-190